Cipher Pharmaceuticals to present at BIO CEO & Investor Conference 2015

MISSISSAUGA, ON, Feb. 9, 2015 /CNW/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) today announced that Shawn Patrick O'Brien, President and Chief Executive Officer, will present at the 17^th Annual BIO CEO & Investor Conference in New York City. Cipher is scheduled to present on Monday, February 9, 2015 at 2:00 PM ET. 

A webcast of Cipher's presentation will be available on the Investor Relations section of the Company's website at www.cipherpharma.com.

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals (NASDAQ:CPHR; TSX:CPH) is a growing specialty pharmaceutical company focused on dermatology. Cipher acquires products that fulfill high unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly or through partners. Cipher's key product, a novel version of the acne medication isotretinoin, is marketed as Absorica™ in the U.S. and Epuris® in Canada. Since the Company was founded in 2000, Cipher has achieved regulatory marketing approval in the U.S. and Canada for all three original products and completed eight marketing partnerships, generating growing revenue streams and shareholder value. Cipher is building its dermatology franchise through product licensing and acquisitions.

SOURCE Cipher Pharmaceuticals Inc.

Investors: In Canada: Craig Armitage, TMX Equicom, [phone] ext 278, [email protected]; In the United States: Michael Moore, TMX Equicom, [phone], [email protected]